https://www.marketscreener.com/quote/stock/ACTIVE-BIOTECH-AB-6491412/news/Active-Biotech-Q3-2023-Rights-Issue-Paves-the-Way-for-Phase-II-in-Myelofibrosis-45295401/?utm_source=telegram&utm_medium=social&utm_campaign=share